Status:
COMPLETED
Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
Lead Sponsor:
NMC Specialty Hospital
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
25-70 years
Brief Summary
The investigators aim to develop expert consensus statements on infection control management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in intensive care units (ICU).
Detailed Description
The COVID-19 pandemic has resulted in a considerable change in the infection control protocols in the hospitals, especially ICU. The ICU management of these patients requires robust infection control ...
Eligibility Criteria
Inclusion
- Inclusion criteria for participants Health care professionals involved in the management of COVID-19 patients with publications and expertise in infectious disease, infection control, sepsis, respiratory failure or public health.
- Exclusion Criteria:
- Those who do not accept the invitation or not meeting any of the inclusion criteria.
Exclusion
Key Trial Info
Start Date :
March 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04665960
Start Date
March 29 2021
End Date
May 1 2021
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NMC Specialty Hospital
Dubai, United Arab Emirates, 7832